References
1. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG,
Enriquez-Sarano M. Burden of valvular heart diseases: a population-based
study. The Lancet. 2006;368(9540):1005-11.
2. De Bonis M, Al-Attar N, Antunes M, Borger M, Casselman F, Falk V, et
al. Surgical and interventional management of mitral valve
regurgitation: a position statement from the European Society of
Cardiology Working Groups on Cardiovascular Surgery and Valvular Heart
Disease. European Heart Journal. 2015;37(2):133-9.
3. Praz F, Brugger N, Kassar M, Hunziker L, Moschovitis A, Stortecky S,
et al. Interventional treatment of mitral valve regurgitation: an
alternative to surgery? Swiss Med Wkly. 2019;149:w20023.
4. Detaint D, Sundt TM, Nkomo VT, Scott CG, Tajik AJ, Schaff HV, et al.
Surgical correction of mitral regurgitation in the elderly: outcomes and
recent improvements. Circulation. 2006;114(4):265-72.
5. Szymczyk E, Wierzbowska-Drabik K, Drozdz J, Krzemińska-Pakuła M.
Mitral valve regurgitation is a powerful factor of left ventricular
hypertrophy. Pol Arch Med Wewn. 2008;118(9):478-83.
6. Dujardin KS, Seward JB, Orszulak TA, Schaff HV, Bailey KR, Tajik AJ,
et al. Outcome after surgery for mitral regurgitation. Determinants of
postoperative morbidity and mortality. J Heart Valve Dis.
1997;6(1):17-21.
7. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Guyton RA,
et al. 2014 AHA/ACC Guideline for the Management of Patients With
Valvular Heart Disease: A Report of the American College of
Cardiology/American Heart Association Task Force on Practice Guidelines.
Journal of the American College of Cardiology. 2014;63(22):e57-e185.
8. Zoghbi WA, Adams D, Bonow RO, Enriquez-Sarano M, Foster E, Grayburn
PA, et al. Recommendations for Noninvasive Evaluation of Native Valvular
Regurgitation: A Report from the American Society of Echocardiography
Developed in Collaboration with the Society for Cardiovascular Magnetic
Resonance. Journal of the American Society of Echocardiography.
2017;30(4):303-71.
9. Chew PG, Bounford K, Plein S, Schlosshan D, Greenwood JP.
Multimodality imaging for the quantitative assessment of mitral
regurgitation. Quant Imaging Med Surg. 2018;8(3):342-59.
10. Huang GS, Sheehan FH, Gill EA. Transesophageal echocardiography
simulation: A review of current technology. Echocardiography.
2022;39(1):89-100.
11. Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke
JP, et al. The Strengthening the Reporting of Observational Studies in
Epidemiology (STROBE) statement: guidelines for reporting observational
studies. Annals of internal medicine. 2007;147(8):573-7.
12. Association GAotWM. World Medical Association Declaration of
Helsinki: ethical principles for medical research involving human
subjects. The Journal of the American College of Dentists.
2014;81(3):14-8.
13. Enriquez-Sarano M, Akins CW, Vahanian A. Mitral regurgitation.
Lancet. 2009;373(9672):1382-94.
14. Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Bärwolf C, Levang
OW, et al. A prospective survey of patients with valvular heart disease
in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J.
2003;24(13):1231-43.
15. Carpentier A. Cardiac valve surgery–the ”French correction”. J
Thorac Cardiovasc Surg. 1983;86(3):323-37.
16. Bonow RO, Carabello BA, Kanu C, de Leon AC, Jr., Faxon DP, Freed MD,
et al. ACC/AHA 2006 guidelines for the management of patients with
valvular heart disease: a report of the American College of
Cardiology/American Heart Association Task Force on Practice Guidelines
(writing committee to revise the 1998 Guidelines for the Management of
Patients With Valvular Heart Disease): developed in collaboration with
the Society of Cardiovascular Anesthesiologists: endorsed by the Society
for Cardiovascular Angiography and Interventions and the Society of
Thoracic Surgeons. Circulation. 2006;114(5):e84-231.
17. Goel SS, Bajaj N, Aggarwal B, Gupta S, Poddar KL, Ige M, et al.
Prevalence and outcomes of unoperated patients with severe symptomatic
mitral regurgitation and heart failure: comprehensive analysis to
determine the potential role of MitraClip for this unmet need. J Am Coll
Cardiol. 2014;63(2):185-6.
18. El-Tallawi KC, Messika-Zeitoun D, Zoghbi WA. Assessment of the
severity of native mitral valve regurgitation. Prog Cardiovasc Dis.
2017;60(3):322-33.
19. Vahanian A, Baumgartner H, Bax J, Butchart E, Dion R, Filippatos G,
et al. Guidelines on the management of valvular heart disease: The Task
Force on the Management of Valvular Heart Disease of the European
Society of Cardiology. Eur Heart J. 2007;28(2):230-68.
20. Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD,
Levine RA, et al. Recommendations for evaluation of the severity of
native valvular regurgitation with two-dimensional and Doppler
echocardiography. J Am Soc Echocardiogr. 2003;16(7):777-802.
21. Shanks M, Siebelink HM, Delgado V, van de Veire NR, Ng AC, Sieders
A, et al. Quantitative assessment of mitral regurgitation: comparison
between three-dimensional transesophageal echocardiography and magnetic
resonance imaging. Circ Cardiovasc Imaging. 2010;3(6):694-700.
22. Thavendiranathan P, Liu S, Datta S, Rajagopalan S, Ryan T, Igo SR,
et al. Quantification of chronic functional mitral regurgitation by
automated 3-dimensional peak and integrated proximal isovelocity surface
area and stroke volume techniques using real-time 3-dimensional volume
color Doppler echocardiography: in vitro and clinical validation. Circ
Cardiovasc Imaging. 2013;6(1):125-33.
23. Krieger EV, Lee J, Branch KR, Hamilton-Craig C. Quantitation of
mitral regurgitation with cardiac magnetic resonance imaging: a
systematic review. Heart. 2016;102(23):1864-70.